TW200501967A - Nemorubicin for use in the preparation of a medicament for liver disease - Google Patents
Nemorubicin for use in the preparation of a medicament for liver diseaseInfo
- Publication number
- TW200501967A TW200501967A TW093104565A TW93104565A TW200501967A TW 200501967 A TW200501967 A TW 200501967A TW 093104565 A TW093104565 A TW 093104565A TW 93104565 A TW93104565 A TW 93104565A TW 200501967 A TW200501967 A TW 200501967A
- Authority
- TW
- Taiwan
- Prior art keywords
- nemorubicin
- medicament
- preparation
- liver disease
- mcg
- Prior art date
Links
- CTMCWCONSULRHO-UHQPFXKFSA-N nemorubicin Chemical compound C1CO[C@H](OC)CN1[C@@H]1[C@H](O)[C@H](C)O[C@@H](O[C@@H]2C3=C(O)C=4C(=O)C5=C(OC)C=CC=C5C(=O)C=4C(O)=C3C[C@](O)(C2)C(=O)CO)C1 CTMCWCONSULRHO-UHQPFXKFSA-N 0.000 title abstract 2
- 229950010159 nemorubicin Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 208000019423 liver disease Diseases 0.000 title 1
- 210000001367 artery Anatomy 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03100470 | 2003-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200501967A true TW200501967A (en) | 2005-01-16 |
Family
ID=32921607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093104565A TW200501967A (en) | 2003-02-26 | 2004-02-24 | Nemorubicin for use in the preparation of a medicament for liver disease |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060264388A1 (enExample) |
| EP (1) | EP1596874B1 (enExample) |
| JP (1) | JP2006519209A (enExample) |
| AT (1) | ATE366579T1 (enExample) |
| DE (1) | DE602004007491T2 (enExample) |
| ES (1) | ES2289483T3 (enExample) |
| TW (1) | TW200501967A (enExample) |
| WO (1) | WO2004075904A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100464783C (zh) * | 2004-11-22 | 2009-03-04 | 山东蓝金生物工程有限公司 | 一种含抗肿瘤抗生素的抗癌药物组合物 |
| ES2552718T3 (es) * | 2007-05-11 | 2015-12-01 | Nerviano Medical Sciences S.R.L. | Composición farmacéutica de una antraciclina |
| WO2009126705A2 (en) | 2008-04-10 | 2009-10-15 | Virginia Commonwealth University | Induction of tumor hypoxia for cancer therapy |
| FR2992863B1 (fr) | 2012-07-06 | 2014-08-29 | Chu De Dijon | Composition pharmaceutique pour le traitement du cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9820012D0 (en) * | 1998-09-14 | 1998-11-04 | Pharmacia & Upjohn Spa | Use of an anthracycline derivative for the treatment of a liver tumor |
| GB9909925D0 (en) * | 1999-04-29 | 1999-06-30 | Pharmacia & Upjohn Spa | Combined preparations comprising anthracycline derivatives |
-
2004
- 2004-02-11 US US10/546,234 patent/US20060264388A1/en not_active Abandoned
- 2004-02-11 ES ES04710040T patent/ES2289483T3/es not_active Expired - Lifetime
- 2004-02-11 AT AT04710040T patent/ATE366579T1/de not_active IP Right Cessation
- 2004-02-11 DE DE602004007491T patent/DE602004007491T2/de not_active Expired - Lifetime
- 2004-02-11 EP EP04710040A patent/EP1596874B1/en not_active Expired - Lifetime
- 2004-02-11 WO PCT/EP2004/050112 patent/WO2004075904A1/en not_active Ceased
- 2004-02-11 JP JP2006502019A patent/JP2006519209A/ja active Pending
- 2004-02-24 TW TW093104565A patent/TW200501967A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004007491D1 (de) | 2007-08-23 |
| ATE366579T1 (de) | 2007-08-15 |
| EP1596874B1 (en) | 2007-07-11 |
| DE602004007491T2 (de) | 2008-03-13 |
| WO2004075904A1 (en) | 2004-09-10 |
| ES2289483T3 (es) | 2008-02-01 |
| EP1596874A1 (en) | 2005-11-23 |
| JP2006519209A (ja) | 2006-08-24 |
| US20060264388A1 (en) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05007857A (es) | Moduladores derivados de indol de receptores nucleares de hormonas esteroideas. | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| MX2007006707A (es) | Acidos grasos omega-3 y agente dislipidemico para terapia lipidica. | |
| TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| RU2008122358A (ru) | Лекарственные формы, содержащие ag013736 | |
| EP1558220A4 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
| IL189546A0 (en) | Therapy for the treatment of disease | |
| MXPA05012810A (es) | Formas de dosis oral de memantina. | |
| BR0311701A (pt) | Formulação de dosagem multiparticulada com liberação controlada de lamotrigina, composição farmacêutica, processo para a preparação de uma composição farmacêutica de lamotrigina, método para a redução da flutuação no pico e no depósito da concentração da droga no plasma do sangue de um paciente, método para melhorar a complacência de um paciente pela redução da frequência de dosagem para uma vez por dia, método para a ministração mais segura de lamotrigina, método para proporcionar uma concentração terapêutica de plasma de sangue de lamotrigina e uso da formulação | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| PL370529A1 (en) | Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug | |
| JP2021502392A5 (enExample) | ||
| BR9809694A (pt) | Processo e composição para administração de taxanos oralmente a pacientes humanos | |
| CO5251425A1 (es) | Metodo y composiciones para administrar taxanos oralmente a pacientes humanos | |
| WO2005094899A8 (en) | Clusterin antisense therapy for treatment of cancer | |
| JP2008517991A5 (enExample) | ||
| TW200501967A (en) | Nemorubicin for use in the preparation of a medicament for liver disease | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| EA200800075A1 (ru) | Схема дозирования для празугреля | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| JP2004521140A5 (enExample) | ||
| MX2010006310A (es) | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. |